Clinical Trial Update: A Safety Study of Sacubitril/Valsartan in Japanese Pediatric Patients With Heart Failure Due to Systemic Left Ventricle Systolic Dysfunction Who Have Completed CLCZ696B2319E1 Study [Phase 3]

View source ↗

Summary

A Phase 3 safety study of sacubitril/valsartan in Japanese pediatric patients with heart failure due to systemic left ventricular systolic dysfunction has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Entresto (sacubitril/valsartan)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Heart Failure | Phase 3 | Status: COMPLETED | Results posted: 2025-02-18